nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Dactinomycin—muscle cancer	0.147	0.162	CbGbCtD
Zafirlukast—CYP2E1—Dacarbazine—muscle cancer	0.121	0.133	CbGbCtD
Zafirlukast—ABCG2—Vincristine—muscle cancer	0.0904	0.1	CbGbCtD
Zafirlukast—ABCG2—Etoposide—muscle cancer	0.0828	0.0916	CbGbCtD
Zafirlukast—PTGS1—Etoposide—muscle cancer	0.0764	0.0845	CbGbCtD
Zafirlukast—CYP1A2—Dacarbazine—muscle cancer	0.0698	0.0772	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—muscle cancer	0.059	0.0653	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—muscle cancer	0.0565	0.0625	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—muscle cancer	0.0547	0.0605	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—muscle cancer	0.0441	0.0488	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—muscle cancer	0.0341	0.0378	CbGbCtD
Zafirlukast—CYP3A4—Vincristine—muscle cancer	0.0195	0.0216	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—muscle cancer	0.0192	0.0212	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—muscle cancer	0.0179	0.0198	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—muscle cancer	0.0122	0.0135	CbGbCtD
Zafirlukast—Raised liver function tests—Dactinomycin—muscle cancer	0.00377	0.0393	CcSEcCtD
Zafirlukast—Hepatotoxicity—Dactinomycin—muscle cancer	0.00226	0.0235	CcSEcCtD
Zafirlukast—Numbness—Vincristine—muscle cancer	0.00188	0.0196	CcSEcCtD
Zafirlukast—Sensory loss—Vincristine—muscle cancer	0.0018	0.0187	CcSEcCtD
Zafirlukast—Raised liver function tests—Methotrexate—muscle cancer	0.00164	0.0171	CcSEcCtD
Zafirlukast—Hepatotoxicity—Etoposide—muscle cancer	0.00163	0.017	CcSEcCtD
Zafirlukast—Leukocytoclastic vasculitis—Methotrexate—muscle cancer	0.00154	0.0161	CcSEcCtD
Zafirlukast—Numbness—Etoposide—muscle cancer	0.00152	0.0159	CcSEcCtD
Zafirlukast—Neuropathy—Vincristine—muscle cancer	0.00146	0.0152	CcSEcCtD
Zafirlukast—Sensory loss—Etoposide—muscle cancer	0.00146	0.0152	CcSEcCtD
Zafirlukast—Hepatic failure—Dactinomycin—muscle cancer	0.00141	0.0147	CcSEcCtD
Zafirlukast—Hepatic failure—Vincristine—muscle cancer	0.00126	0.0131	CcSEcCtD
Zafirlukast—Neuropathy—Etoposide—muscle cancer	0.00118	0.0123	CcSEcCtD
Zafirlukast—Liver function test abnormal—Dactinomycin—muscle cancer	0.00117	0.0122	CcSEcCtD
Zafirlukast—Haematemesis—Methotrexate—muscle cancer	0.00109	0.0113	CcSEcCtD
Zafirlukast—Swelling—Etoposide—muscle cancer	0.00104	0.0108	CcSEcCtD
Zafirlukast—Neutropenia—Dactinomycin—muscle cancer	0.00102	0.0107	CcSEcCtD
Zafirlukast—Hepatotoxicity—Methotrexate—muscle cancer	0.000978	0.0102	CcSEcCtD
Zafirlukast—Haematemesis—Doxorubicin—muscle cancer	0.000941	0.00982	CcSEcCtD
Zafirlukast—Neutropenia—Vincristine—muscle cancer	0.000913	0.00952	CcSEcCtD
Zafirlukast—Agranulocytosis—Dactinomycin—muscle cancer	0.00091	0.00948	CcSEcCtD
Zafirlukast—Blister—Doxorubicin—muscle cancer	0.000907	0.00946	CcSEcCtD
Zafirlukast—Haemoptysis—Doxorubicin—muscle cancer	0.000884	0.00921	CcSEcCtD
Zafirlukast—Hepatitis—Dactinomycin—muscle cancer	0.000875	0.00912	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Vincristine—muscle cancer	0.000854	0.0089	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Methotrexate—muscle cancer	0.000831	0.00866	CcSEcCtD
Zafirlukast—Blood disorder—Doxorubicin—muscle cancer	0.000783	0.00816	CcSEcCtD
Zafirlukast—Hypoaesthesia—Vincristine—muscle cancer	0.000778	0.00811	CcSEcCtD
Zafirlukast—Liver injury—Doxorubicin—muscle cancer	0.000777	0.0081	CcSEcCtD
Zafirlukast—Vasculitis—Methotrexate—muscle cancer	0.000774	0.00807	CcSEcCtD
Zafirlukast—Neutropenia—Etoposide—muscle cancer	0.00074	0.00771	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Doxorubicin—muscle cancer	0.000724	0.00755	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Doxorubicin—muscle cancer	0.000719	0.0075	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dactinomycin—muscle cancer	0.000707	0.00737	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Etoposide—muscle cancer	0.000692	0.00721	CcSEcCtD
Zafirlukast—Jaundice—Etoposide—muscle cancer	0.000688	0.00717	CcSEcCtD
Zafirlukast—Malaise—Dactinomycin—muscle cancer	0.000687	0.00716	CcSEcCtD
Zafirlukast—Agranulocytosis—Etoposide—muscle cancer	0.000658	0.00686	CcSEcCtD
Zafirlukast—Back pain—Vincristine—muscle cancer	0.000658	0.00686	CcSEcCtD
Zafirlukast—Myalgia—Dactinomycin—muscle cancer	0.000648	0.00676	CcSEcCtD
Zafirlukast—Discomfort—Dactinomycin—muscle cancer	0.000641	0.00668	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—muscle cancer	0.000635	0.00662	CcSEcCtD
Zafirlukast—Hypoaesthesia—Etoposide—muscle cancer	0.00063	0.00657	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—muscle cancer	0.000622	0.00648	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—muscle cancer	0.000618	0.00644	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—muscle cancer	0.000614	0.0064	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—muscle cancer	0.00061	0.00636	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—muscle cancer	0.000609	0.00635	CcSEcCtD
Zafirlukast—Myalgia—Vincristine—muscle cancer	0.000579	0.00604	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000566	0.0059	CcSEcCtD
Zafirlukast—Oedema—Vincristine—muscle cancer	0.000555	0.00579	CcSEcCtD
Zafirlukast—Infection—Vincristine—muscle cancer	0.000552	0.00575	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vincristine—muscle cancer	0.000544	0.00567	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000543	0.00566	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—muscle cancer	0.000536	0.00559	CcSEcCtD
Zafirlukast—Back pain—Etoposide—muscle cancer	0.000533	0.00556	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—muscle cancer	0.000532	0.00554	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—muscle cancer	0.000528	0.00551	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—muscle cancer	0.000512	0.00534	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—muscle cancer	0.000512	0.00533	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000508	0.0053	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—muscle cancer	0.000506	0.00528	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000506	0.00528	CcSEcCtD
Zafirlukast—Insomnia—Vincristine—muscle cancer	0.000502	0.00524	CcSEcCtD
Zafirlukast—Malaise—Etoposide—muscle cancer	0.000497	0.00518	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—muscle cancer	0.000497	0.00518	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—muscle cancer	0.000491	0.00512	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—muscle cancer	0.000491	0.00512	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vincristine—muscle cancer	0.00048	0.005	CcSEcCtD
Zafirlukast—Fatigue—Vincristine—muscle cancer	0.000479	0.00499	CcSEcCtD
Zafirlukast—Pain—Vincristine—muscle cancer	0.000475	0.00495	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—muscle cancer	0.000469	0.00489	CcSEcCtD
Zafirlukast—Discomfort—Etoposide—muscle cancer	0.000464	0.00483	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—muscle cancer	0.000458	0.00478	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—muscle cancer	0.000454	0.00474	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vincristine—muscle cancer	0.000454	0.00474	CcSEcCtD
Zafirlukast—Infection—Etoposide—muscle cancer	0.000447	0.00466	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—muscle cancer	0.000446	0.00465	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—muscle cancer	0.000443	0.00462	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—muscle cancer	0.000441	0.00459	CcSEcCtD
Zafirlukast—Abdominal pain—Vincristine—muscle cancer	0.000439	0.00458	CcSEcCtD
Zafirlukast—Body temperature increased—Vincristine—muscle cancer	0.000439	0.00458	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—muscle cancer	0.000438	0.00457	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—muscle cancer	0.000425	0.00443	CcSEcCtD
Zafirlukast—Hypersensitivity—Vincristine—muscle cancer	0.000409	0.00427	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—muscle cancer	0.000406	0.00424	CcSEcCtD
Zafirlukast—Asthenia—Vincristine—muscle cancer	0.000399	0.00415	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—muscle cancer	0.000395	0.00412	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—muscle cancer	0.000394	0.00411	CcSEcCtD
Zafirlukast—Rash—Dactinomycin—muscle cancer	0.000392	0.00409	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—muscle cancer	0.000388	0.00405	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—muscle cancer	0.000388	0.00404	CcSEcCtD
Zafirlukast—Pain—Etoposide—muscle cancer	0.000385	0.00401	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—muscle cancer	0.000384	0.004	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—muscle cancer	0.000381	0.00397	CcSEcCtD
Zafirlukast—Diarrhoea—Vincristine—muscle cancer	0.00038	0.00396	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—muscle cancer	0.000379	0.00395	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—muscle cancer	0.000379	0.00395	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—muscle cancer	0.000371	0.00387	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—muscle cancer	0.000369	0.00385	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—muscle cancer	0.000368	0.00384	CcSEcCtD
Zafirlukast—Dizziness—Vincristine—muscle cancer	0.000367	0.00383	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000359	0.00374	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—muscle cancer	0.000357	0.00373	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—muscle cancer	0.000357	0.00372	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—muscle cancer	0.000356	0.00371	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—muscle cancer	0.000356	0.00371	CcSEcCtD
Zafirlukast—Vomiting—Vincristine—muscle cancer	0.000353	0.00368	CcSEcCtD
Zafirlukast—Rash—Vincristine—muscle cancer	0.00035	0.00365	CcSEcCtD
Zafirlukast—Dermatitis—Vincristine—muscle cancer	0.00035	0.00365	CcSEcCtD
Zafirlukast—Headache—Vincristine—muscle cancer	0.000348	0.00363	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—muscle cancer	0.000343	0.00358	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—muscle cancer	0.000341	0.00356	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—muscle cancer	0.000331	0.00346	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—muscle cancer	0.00033	0.00344	CcSEcCtD
Zafirlukast—Nausea—Vincristine—muscle cancer	0.00033	0.00344	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—muscle cancer	0.000328	0.00342	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—muscle cancer	0.000328	0.00342	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—muscle cancer	0.000327	0.00341	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—muscle cancer	0.000323	0.00337	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—muscle cancer	0.000319	0.00333	CcSEcCtD
Zafirlukast—Pruritus—Etoposide—muscle cancer	0.000318	0.00332	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—muscle cancer	0.000308	0.00321	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—muscle cancer	0.000306	0.00319	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—muscle cancer	0.000298	0.0031	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—muscle cancer	0.000298	0.0031	CcSEcCtD
Zafirlukast—Vomiting—Etoposide—muscle cancer	0.000286	0.00298	CcSEcCtD
Zafirlukast—Rash—Etoposide—muscle cancer	0.000284	0.00296	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—muscle cancer	0.000283	0.00295	CcSEcCtD
Zafirlukast—Headache—Etoposide—muscle cancer	0.000282	0.00294	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—muscle cancer	0.000281	0.00293	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—muscle cancer	0.000281	0.00293	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—muscle cancer	0.000278	0.0029	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—muscle cancer	0.000277	0.00288	CcSEcCtD
Zafirlukast—Infection—Methotrexate—muscle cancer	0.000268	0.00279	CcSEcCtD
Zafirlukast—Nausea—Etoposide—muscle cancer	0.000267	0.00279	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—muscle cancer	0.000265	0.00277	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—muscle cancer	0.000264	0.00275	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—muscle cancer	0.000258	0.00269	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000246	0.00256	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—muscle cancer	0.000244	0.00254	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—muscle cancer	0.000243	0.00254	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—muscle cancer	0.000243	0.00254	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—muscle cancer	0.000241	0.00251	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—muscle cancer	0.000237	0.00247	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—muscle cancer	0.000233	0.00243	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000233	0.00243	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—muscle cancer	0.000232	0.00242	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—muscle cancer	0.000232	0.00242	CcSEcCtD
Zafirlukast—Pain—Methotrexate—muscle cancer	0.00023	0.0024	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—muscle cancer	0.000228	0.00238	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—muscle cancer	0.000222	0.00232	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—muscle cancer	0.00022	0.0023	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—muscle cancer	0.000214	0.00223	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—muscle cancer	0.000213	0.00222	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—muscle cancer	0.000213	0.00222	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000213	0.00222	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—muscle cancer	0.000211	0.0022	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—muscle cancer	0.000205	0.00214	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000201	0.0021	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—muscle cancer	0.000201	0.0021	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—muscle cancer	0.0002	0.00208	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—muscle cancer	0.000199	0.00207	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—muscle cancer	0.000193	0.00202	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—muscle cancer	0.000192	0.002	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000191	0.00199	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—muscle cancer	0.000191	0.00199	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—muscle cancer	0.000185	0.00193	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—muscle cancer	0.000184	0.00192	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—muscle cancer	0.000184	0.00192	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—muscle cancer	0.000184	0.00192	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—muscle cancer	0.000178	0.00186	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—muscle cancer	0.000172	0.00179	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—muscle cancer	0.000171	0.00179	CcSEcCtD
Zafirlukast—Rash—Methotrexate—muscle cancer	0.00017	0.00177	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—muscle cancer	0.00017	0.00177	CcSEcCtD
Zafirlukast—Headache—Methotrexate—muscle cancer	0.000169	0.00176	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—muscle cancer	0.000167	0.00175	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—muscle cancer	0.000165	0.00172	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—muscle cancer	0.00016	0.00167	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—muscle cancer	0.00016	0.00166	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—muscle cancer	0.000154	0.00161	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—muscle cancer	0.000148	0.00155	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—muscle cancer	0.000147	0.00153	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—muscle cancer	0.000147	0.00153	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—muscle cancer	0.000146	0.00152	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—muscle cancer	0.000139	0.00145	CcSEcCtD
